Авторизація
|
Американські ринки пристроїв для нейростимуляції (U.S. Markets for Neurostimulation Products) One of the most promising medical device markets to date is neurostimulation. This newest report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the United States (U.S.) neurostimulation products market. This market, as defined in this report, includes several types of implantable neurostimulation devices including cochlear implants and systems for deep brain stimulation, gastric nerve stimulation, sacral nerve stimulation, spinal cord stimulation, and vagus nerve stimulation.
Publisher: Medtech Insight
Neurostimulation currently treats several debilitating conditions including chronic pain, epilepsy, essential tremor and dystonia, gastroparesis, hearing loss, incontinence, major treatment-resistant depression, obsessive-compulsive disorder, and Parkinson’s disease. Emerging and exciting areas of development include the treatment of large-population diseases and disorders including Alzheimer’s disease, blindness, chronic migraines, morbid obesity, obstructive sleep apnea, paralysis, stroke, and tinnitus, with the potential to expand to several other applications. In addition to implantable neurostimulation systems and transcutaneous electrical nerve stimulators (TENS), this report from Medtech Insight includes analyses of transcranial magnetic nerve stimulation systems and other noninvasive electrical nerve stimulators. In addition, incidence and procedure numbers are provided for some of the most common major neurologic diseases and disorders. The U.S. neurostimulation products market is poised for significant growth over the next decade due to factors such as the aging population, growth in age-related neurologic diseases and disorders, and the need for effective, alternative therapies. In 2009, the U.S. market for implantable neurostimulation products was estimated at $1,227.7 million; this market is expected to grow at a compound annual rate of 16.3% during the forecast period covered by this report, reaching more than $2.6 billion in the year 2014. At the same time, the market for TENS is projected to grow at a compound annual rate of 8.3%, reaching an estimated $113.8 million in the year 2014. TABLE OF CONTENTS Executive Summary i. Implantable Neurostimulation Products a. Market Analysis ii. Transcutaneous Electrical Nerve Stimulation Products a. Market Analysis iii. Methodology Exhibit ES-1: Selected Neurologic Conditions, Prevalence and Potential Neurostimulation Patient Population Exhibit ES-2: Neurostimulation Products, Combined Market Forecast, 2009-2014 Exhibit ES-3: 2009, Neurostimulation Products Market, Estimated Percentage of Sales, by Application Exhibit ES-4: Neurostimulation Products (Including Cochlear Implants), Market Forecast, 2009-2014 Exhibit ES-5: Transcutaneous Electrical Nerve Stimulators, Market Forecast, 2009-2014 1. OVERVIEW OF THE NERVOUS SYSTEM AND selected neurologic diseases/DISORDERS 1.1 The Nervous System 1.1.1 Sacral Nerves1.2 Neurologic and Other Diseases/Disorders 1.2.1 Alzheimer’s Disease 1.2.4.1 Etiology 1.2.5 ObesityExhibit 1-1: United States Population, by Age Group, Selected Years, 2000-2050 Exhibit 1-2: Selected Neurologic Conditions, Prevalence and Potential Neurostimulation Patient Population Exhibit 1-3: The Sacral Nervous System Exhibit 1-4: The Vagus Nerve Exhibit 1-5: Anatomy of the Brain Exhibit 1-6: Anatomy of the Spine Exhibit 1-7: Alzheimer’s Disease, Facts and Figures Exhibit 1-8: 2010, Alzheimer’s Disease Medications Exhibit 1-9: Depression, Facts and Figures Exhibit 1-10: Epilepsy, Facts and Figures Exhibit 1-11: Gastroparesis, Facts and Figures Exhibit 1-12: 2010, Obesity Comorbidities Exhibit 1-13: Obesity, Facts and Figures Exhibit 1-14: Urinary Incontinence, Facts and Figures Exhibit 1-15: 2010, Treatment Options for Urinary Incontinence Exhibit 1-16: Acute Pain, Facts and Figures Exhibit 1-17: Chronic Pain, Facts and Figures Exhibit 1-18: Migraine Headache, Facts and Figures Exhibit 1-19: Parkinson’s Disease, Facts and Figures Exhibit 1-20: Essential Tremor, Facts and Figures Exhibit 1-21: Obsessive-Compulsive Disorder, Facts and Figures Exhibit 1-22: Stroke, Facts and Figures Exhibit 1-23: Obstructive Sleep Apnea, Facts and Figures Exhibit 1-24: Tinnitus, Facts and Figures 2. NEUROSTIMULATION PRODUCTS MARKET 2.1 Implantable Neurostimulators 2.1.1 Cortical Stimulators2.2 Core Treatment Areas for Implantable Neurostimulators 2.2.1 Major Depression2.3 Emerging Applications for Neurostimulation 2.3.1 Alzheimer’s Disease2.4 Market Forecast 2.5 Competitive Analysis Exhibit 2-1: 2010, Selected Advantages and Disadvantages of Neurostimulation Therapy Exhibit 2-2: 2009, Patients Who Have Received Neurostimulation Implants, by Selected Neurologic Condition Exhibit 2-3: 2010, Established Neurostimulation Therapies and Leading Suppliers Exhibit 2-4: Deep Brain Stimulation Exhibit 2-5: Neurostimulation in Suppressing Epileptic Seizures; NeuroPace’s Responsive Neurostimulator Therapy Exhibit 2-6: Neurostimulation in the Treatment of Gastroparesis, Medtronic’s Enterra Exhibit 2-7: Cochlear’s Nucleus Freedom Implant Exhibit 2-8: Medtronic’s InterStim Therapy System Exhibit 2-9: Medtronic’s Neurostimulators for the Treatment of Chronic Pain Exhibit 2-10: St. Jude Medical’s Neurostimulators for the Treatment of Chronic Pain Exhibit 2-11: Medtronic’s Activa Therapy for Parkinson’s Disease and Essential Tremor Exhibit 2-12: 2010, Selected Current and Emerging Neurostimulation Systems Exhibit 2-13: Second Sight Medical Products’ Intraocular Retinal Prosthesis Exhibit 2-14: 2009, Neurostimulation Products Market, Estimated Percentage of Sales, by Application Exhibit 2-15: Neurostimulation Products, Selected Market Drivers and Limiters Exhibit 2-16: Neurostimulation Products (Including Cochlear Implants), Market Forecast, 2009-2014 Exhibit 2-17: Neurostimulation Products (Excluding Cochlear Implants), Market Forecast, 2009-2014 Exhibit 2-18: Cochlear Implants, Market Forecast, 2009-2014 Exhibit 2-19: 2009, Neurostimulation Products Market (Including Cochlear Implants), Share by Supplier Exhibit 2-20: 2009, Neurostimulation Products Market (Excluding Cochlear Implants), Share by Supplier Exhibit 2-21: 2009, Cochlear Implants Market, Share by Supplier 3. Transcutaneous electrical nerve stimulation products market 3.1 Overview 3.1.1 Products3.2 Other Noninvasive Electrical Stimulation Technologies 3.2.1 Transcranial Magnetic Stimulation/Other Magnetic StimulationExhibit 3-1: 2010, Selected Conditions That May Be Treated Using Transcutaneous Electrical Nerve Stimulation Exhibit 3-2: Dynatronics’ Sympathetic Therapy Systems Exhibit 3-3: Zynex Medical’s Transcutaneous Electrical Nerve Stimulation Systems Exhibit 3-4: 2010, Selected Transcutaneous Electrical Nerve Stimulation Devices Exhibit 3-5: Transcutaneous Electrical Nerve Stimulators, Market Forecast, 2009-2014 Exhibit 3-6: 2009, Transcutaneous Electrical Nerve Stimulators Market, Share by Supplier Exhibit 3-7: 2010, Selected Transcranial and Other Magnetic Stimulation Systems Exhibit 3-8: Innovative Neurotronics’ WalkAide 4. Company Profiles 4.1 Advanced Bionics Corporation/Sonova Holding AG 4.2 Apnex Medical, Inc. 4.3 BioMedical Life Systems, Inc. 4.4 Boston Scientific Corporation 4.5 Cochlear LTD 4.6 Cyberonics, Inc. 4.7 DJO, Inc. 4.8 Dynatronics Corporation 4.9 EnteroMedics, Inc. 4.10 MED-EL Corporation 4.11 Medtronic, Inc. 4.12 RS Medical, Inc. 4.13 Second Sight Medical Products, Inc. 4.14 St. Jude Medical, Inc. Перекладач: translate.google.com |
Новини
03.03.2023 Науково доведено: через смартфони ви можете старіти швидше
24.02.2023 Стимуляція спинного мозку відновлює постінсультну функцію рук 17.02.2023 Вчені відкрили здатність жирної їжі руйнувати мозок 10.02.2023 В Індії розробили неінвазивний тест, який використовує штучний інтелект для виявлення раку молочної залози 01.02.2023 Як спостереження за світанками та заходами сонця впливає на здоров'я – вчені 25.01.2023 Аналіз крові для ранньої діагностики хвороби Альцгеймера розробили вчені 18.01.2023 Людина з серцем свині. Пацієнту вперше пересадили серце тварини 11.01.2023 Вчені пояснили, чому оливкову олію варто пити ложками 21.11.2022 Вчені виявили ще одну причину високого ризику атеросклерозу 18.11.2022 Імплантована помпа доставила протиракові ліки у пухлини мозку 16.11.2022 Шум вночі може бути причиною безсоння та серцево-судинних захворювань 14.11.2022 ЩО ТРЕБА ЗНАТИ ПРО ЦУКРОВИЙ ДІАБЕТ: ТИПИ, СИМПТОМИ, УСКЛАДНЕННЯ 11.11.2022 Виявилося, в епідемії ожиріння винен лише один тип їжі 09.11.2022 Проказа: давня хвороба, здатна регенерувати органи 07.11.2022 "Чарівні гриби" можуть лікувати важку депресію 04.11.2022 Нове випробування пропонує переваги CV з EPA: RESPECT-EPA 02.11.2022 Майже 500 українських медиків завершили навчання з тактичної медицини 01.11.2022 Чи можна людям з діабетом пити алкоголь 31.10.2022 Знайдено овоч, здатний знизити цукор у крові відразу на 20% 28.10.2022 Людська печінка може працювати 100 років |